GlassScriptPhysician profile
Philip Zhou
NPI 1801525050
$1,478.74
in general payments reported to CMS, 2019-2025
8 companies · $1,248 in 2025
The $1,248 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $109 · 2024: $122 · 2025: $1,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $398.22 | 2025 | Clearpath, Streamline, Kahook Dual Blade |
| Alcon Vision LLC | $393.07 | 2025 | Clareon, Rhopressa, Rocklatan |
| Sight Sciences, INC. | $234.60 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ani Pharmaceuticals, INC. | $164.01 | 2025 | Purified Cortrophin Gel, Iluvien |
| Harrow Eye, LLC | $125.00 | 2025 | Iheezo, Triesence |
| Johnson & Johnson Surgical Vision, INC. | $109.09 | 2023 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Regeneron Healthcare Solutions, INC. | $34.02 | 2024 | Eylea Hd |
| Glaukos Corporation | $20.73 | 2025 | Istent Infinite, Idosetr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.